oalib

Publish in OALib Journal

ISSN: 2333-9721

APC: Only $99

Submit

Any time

2019 ( 2 )

2018 ( 18 )

2017 ( 14 )

2016 ( 23 )

Custom range...

Search Results: 1 - 10 of 9254 matches for " Steven Lingafelter "
All listed articles are free for downloading (OA Articles)
Page 1 /9254
Display every page Item
New records of Caribbomerus from Hispaniola with redescription of C. elongatus (Fisher) and a key to the genus in the West Indies (Coleoptera, Cerambycidae, Cerambycinae, Graciliini)
Steven Lingafelter
ZooKeys , 2011, DOI: 10.3897/zookeys.85.826
Abstract: Three species of Caribbomerus Vitali are newly recorded for the Dominican Republic: C. decoratus (Zayas), C. elongatus (Fisher), and C. asperatus (Fisher). The first two also represent first records for Hispaniola. Caribbomerus elongatus (Fisher) is redescribed based on additional material, including the first known males. A key to the species of the genus from the West Indies is provided.
New myrmecomorphous longhorned beetles from Haiti and the Dominican Republic with a key to Anaglyptini and Tillomorphini of Hispaniola (Coleoptera, Cerambycidae, Cerambycinae)
Steven Lingafelter
ZooKeys , 2011, DOI: 10.3897/zookeys.106.1470
Abstract: First records of the tribes Anaglyptini and Tillomorphini (Coleoptera: Cerambycidae: Cerambycinae) are documented for Hispaniola. A new genus of a highly myrmecomorphic longhorned beetle (Licracantha gen. n.) is described and illustrated based on one species (Licracantha formicaria sp. n.) and provisionally assigned to Tillomorphini. Three other new species of ant mimic longhorned beetles are described and illustrated: Calliclytus macoris sp. n. (Tillomorphini), Tilloclytus baoruco sp. n., and Tilloclytus neiba sp. n. (Anaglyptini). An identification key and distribution map to all known Hispaniolan species of these two tribes are presented.
Hispaniolan Hemilophini (Coleoptera, Cerambycidae, Lamiinae)
Steven Lingafelter
ZooKeys , 2013, DOI: 10.3897/zookeys.258.4391
Abstract: The Tribe Hemilophini (Lamiinae) is reviewed for Hispaniola and an identification key is provided. Fifteen species are now known from the island, including one new species of Adesmus (A. fortunei from Pedernales and La Vega Provinces, Dominican Republic), one new species of Oedudes (O. anulatus from Peravia and La Vega Provinces, Dominican Republic), and five new species of Calocosmus (C. contortus from San Cristóbal Province, C. punctatus from Peravia Province, C. rawlinsi from Elías Pi a Province, C. robustus from La Vega Province, and C. thonalmus from La Altagracia Province, all in the Dominican Republic). Oedudes and Adesmus are new island and country records for Hispaniola and Dominican Republic, respectively. Calocosmus holosericeus Gahan is a new synonym of Calocosmus janus Bates. In addition to the new species, five new country records and four new island records are presented for Calocosmus.
The genus Leptostylopsis of Hispaniola (Coleoptera, Cerambycidae, Acanthocinini)
Steven Lingafelter,Charyn Micheli
ZooKeys , 2009, DOI: 10.3897/zookeys.17.217
Abstract: The generic differences and similarities between Leptostylus LeConte and Leptostylopsis Dillon (Coleoptera: Cerambycidae: Acanthocinini) are discussed. Leptostylopsis is redescribed and the following species are transferred from Leptostylus to Leptostylopsis: Leptostylopsis annulipes (Fisher 1942), comb. n.; Leptostylopsis poeyi (Fisher 1925), comb. n.; and Leptostylopsis viridicomus (Fisher 1942), comb. n. Leptostylopsis hispaniolae (Fisher 1942) is a syn. n. of Leptostylopsis annulipes (Fisher 1942). Seven new species of Leptostylopsis from Hispaniola are diagnosed, described, and illustrated: L. basifulvus Lingafelter and Micheli, sp. n.; L. caliginosus Lingafelter and Micheli, sp. n.; L. chlorescens Lingafelter and Micheli, sp. n.; L. humerofulvus Lingafelter and Micheli, sp. n.; L. perfasciatus Lingafelter and Micheli, sp. n.; L. puntacanaensis Lingafelter and Micheli, sp. n.; and L. thomasi Lingafelter and Micheli, sp. n. Redescriptions and distributional data are provided for the six previously described species known from Hispaniola, and a dichotomous key to all thirteen species of Leptostylopsis from Hispaniola is provided.
Preimaginal Stages of the Emerald Ash Borer, Agrilus planipennis Fairmaire (Coleoptera: Buprestidae): An Invasive Pest on Ash Trees (Fraxinus)
M. Lourdes Chamorro, Mark G. Volkovitsh, Therese M. Poland, Robert A. Haack, Steven W. Lingafelter
PLOS ONE , 2012, DOI: 10.1371/journal.pone.0033185
Abstract: This study provides the most detailed description of the immature stages of Agrilus planipennis Fairmaire to date and illustrates suites of larval characters useful in distinguishing among Agrilus Curtis species and instars. Immature stages of eight species of Agrilus were examined and imaged using light and scanning electron microscopy. For A. planipennis all preimaginal stages (egg, instars I-IV, prepupa and pupa) were described. A combination of 14 character states were identified that serve to identify larvae of A. planipennis. Our results support the segregation of Agrilus larvae into two informal assemblages based on characters of the mouthparts, prothorax, and abdomen: the A. viridis and A. ater assemblages, with A. planipennis being more similar to the former. Additional evidence is provided in favor of excluding A. planipennis from the subgenus Uragrilus.
Sorafenib for advanced renal cell carcinoma in real-life practice: a literature review  [PDF]
Steven Simoens
Health (Health) , 2011, DOI: 10.4236/health.2011.32016
Abstract: Sorafenib is a new treatment indicated for patients with advanced renal cell carcinoma who have failed prior cytokine-based therapy or are considered unsuitable for such therapy. Although treatment with sorafenib under ‘ideal trial conditions’ has been extensively studied, registration and reimbursement authorities are also interested in the behavior of sorafenib in real-life practice. This study aims to conduct a literature review of the dosage and treatment duration; safety, tolerability and effectiveness; costs and cost-effectiveness of sorafenib in routine clinical care. Studies were identified by searching PubMed, Embase, Centre for Reviews and Dissemination databases, Cochrane Database of Systematic Reviews, and EconLit up to November 2010. The literature search included articles published in peer-reviewed journals, congress abstracts, and internal studies of Bayer Schering Pharma. Eight studies were included. An open-label study observed stable disease for at least eight weeks in 80% of patients. The most common drug-related adverse events were hand-foot skin reaction, rash, hypertension, and fatigue. Although treatment with sorafenib led to fewer dose reductions, it was also associated with a shorter treatment duration, less time to pro-gression and a shorter survival time as compared to sunitinib. Monthly health care costs were lower with sorafenib as compared to sunitinib. A post-marketing surveillance study showed that patients rated the tolerability and effectiveness of sorafenib as very good, good or sufficient. In conclusion, the current evidence is too limited to derive conclusions and existing studies suffer from methodological shortcomings.
Budget impact of a 10% ready-to-use intravenous immunoglobulin in the treatment of primary immunodeficiency in Belgium  [PDF]
Steven Simoens
Health (Health) , 2009, DOI: 10.4236/health.2009.13030
Abstract: The aim of this study is to compute the budget impact of adopting Kiovig, a new ready-to-use 10% liquid immunoglobulin preparation, as a treatment for primary immunodeficiency from the perspective of the Belgian health care payer. The analysis compared the “world with Kiovig” to the “world without Kiovig” and calculated how a change in the mix of immunoglobulins used to treat primary immunodeficiency would impact drug spending during 2010-2014. Data on the number of patients, immunoglobulin market shares and drug unit costs were derived from the IMS Health hospital disease database and from Belgian sources. The number of Belgian patients suffering from primary immunodefi-ciency is expected to increase from 2,378 pa-tients in 2010 to 2,447 patients in 2014. The budget impact of adopting Kiovig is likely to be modest, raising the immunoglobulin drug bud- get for this patient population by 0.4%-1.3% per year. The budgetary increase originated from the higher price of Kiovig as compared with other products, although the impact of Kiovig was limited by its anticipated slow market penetra-tion. There is a need for more and better data on the Belgian immunoglobulin market.
The Dialectical Relationship between Religion and the Ideology of Science  [PDF]
Steven Gerardi
Sociology Mind (SM) , 2012, DOI: 10.4236/sm.2012.21006
Abstract: This Original effort suggests that analogous to Max Weber’s “Spirit of Capitalism” found in The Protestant Ethic and the Spirit of Capitalism, the disenchantment and demystification of the ancient Judaism ethic code of behavior, is a major factor in the rise of the ideology of science.
Social Change, Historical Modes-of-Production and the Tendency toward Capital Concentration  [PDF]
Steven Gerardi
Sociology Mind (SM) , 2012, DOI: 10.4236/sm.2012.23032
Abstract: This effort suggests that a key component within the conflict paradigm often not referred to in the literature is the Tendency Toward Capital Concentration as a function of historical changing economic modes-of-production. Furthermore, modes-of-production change is the primary force of social change within the conflict view. This effort will cite several examples of changing economic modes-of-production as the result of Tendency Toward Capital Concentration, which has acted as force of social change.
Prolonged Radiographic Stabilization of a Metastatic Octreotide Scan-Positive Poorly Differentiated Neuroendocrine Tumor Using Octreotide Acetate Therapy Alone  [PDF]
Steven Sorscher
Journal of Cancer Therapy (JCT) , 2013, DOI: 10.4236/jct.2013.47132
Abstract:

Pancreatic poorly differentiated neuroendocrine tumors (PDNETs) are a subtype of neuroendocrine Tumors (NETs) clinically distinguished by their much more rapid growth and immunohistochemically diagnosed by having a higher Ki-67 cancer cell staining percentage compared to their well or intermediately differentiated NET counterparts. While standard first line treatment for metastatic well or intermediately differentiated pancreatic NETs typically involves octreotide acetate therapy, here I report, to my knowledge, the first case of a patient with a pancreatic PDNET with radiographic stabilization of his disease with octreotide acetate use alone. Octreotide acetate was chosen after first establishing that, based on his octreotide scan, receptors might be targeted using the octreotide analog.

Page 1 /9254
Display every page Item


Home
Copyright © 2008-2017 Open Access Library. All rights reserved.